BIOA - BioAge Labs, Inc.
4.04
-0.070 -1.733%
Share volume: 114,684
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$4.11
-0.07
-0.02%
Summary score
42%
Profitability
35%
Dept financing
28%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-6.1%
Return on sales
-1133.43%
Return on invested capital
0%
Total debt ratio
8.58%
Debt ratio change over timeo
0%
Current Ratio
14.72%
Quick Ratio
0%
Cash Position Ratio
13.71%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-6.1%
Return on sales
-1133.43%
Return on invested capital
0%
Total debt ratio
8.58%
Debt ratio change over timeo
0%
Current Ratio
14.72%
Quick Ratio
0%
Cash Position Ratio
13.71%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-4.78%
Return on sales
-1133.43%
Return on invested capital
0%
Total debt ratio
8.92%
Debt ratio change over time
0%
Current Ratio
13.68%
Quick Ratio
0%
Cash Position Ratio
10.85%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BIOA | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 14.28% | 9.23% | 0% |
| Return on assets | -6.1% | 4.23% | 3.2% | 0% |
| Return on sales | -1133.43% | 27.89% | 25.03% | 0% |
| Return on invested capital | 0% | 8.36% | 9.37% | 0% |
| Profitability | 0% | 97% | 83% | 0% |
| Total debt ratio | 8.58% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 0% | -11.36% | -57.43% | 0% |
| Dept financing | 28% | 25% | 18% | 0% |
| Current Ratio | 14.72% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 13.71% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 26% | 28% | 0% |
| Short-term ratios | BIOA | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -6.1% | 4.32% | 3.49% | 0% |
| Return on sales | -1133.43% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 8.58% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 25% | 18% | 0% |
| Current Ratio | 14.72% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 13.71% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 27% | 26% | 0% |
